Losartan Potassium and Hydrochlorothiazide Tablets Recalled for Elevated Azido Impurity
Preferred Pharmaceuticals recalls Losartan Potassium & HCTZ Tablets (50mg/12.5mg) in Florida and California due to elevated azido impurity levels above acceptable manufacturing limits.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II pharmaceutical recall with CGMP deviations and elevated impurity levels above acceptable limits. No reported illnesses or hospitalizations qualify this as a risk-of-harm product without confirmed injury.
Plain-English summary
Preferred Pharmaceuticals, Inc. is recalling Losartan Potassium & HCTZ Tablets 50mg/12.5mg (NDC 68788-7758-09) due to Current Good Manufacturing Practice (CGMP) deviations. The affected lots are K1721D (expiration 4/30/2023) with 31 bottles and K1021E (expiration 7/31/2023) with 5 bottles.
The recall was initiated because azido impurity levels in these lots were observed to be above acceptable limits. These impurities were identified during manufacturing quality testing.
The affected products were distributed in Florida and California only. Patients taking these medications should consult with their healthcare provider or pharmacist regarding the recall.
Consumers who have purchased these products should contact their pharmacy or Preferred Pharmaceuticals, Inc. for instructions on return or disposal.
The recalled product
- Product
- Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5, Pkg Size: 90, NDC: 68788-7758-09.
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Category
- Drug — Blood Pressure Medication
- Hazard
- impurity-azido
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot: K1721D
- EXP: 4/30/2023
- NDC: 68788-7758-09
- Lot: K1021E
- EXP: 7/31/2023
- NDC: 68788-7758-09.
Distribution
Distributed in 2 states:
- CA
- FL
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27